{"id":"https://openalex.org/W2411288993","doi":null,"title":"Trimetrexate: experience with solid tumors.","display_name":"Trimetrexate: experience with solid tumors.","publication_year":1997,"publication_date":"1997-10-01","ids":{"openalex":"https://openalex.org/W2411288993","mag":"2411288993","pmid":"https://pubmed.ncbi.nlm.nih.gov/9420024"},"language":"en","primary_location":{"id":"pmid:9420024","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9420024","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069896983","display_name":"Daniel G Haller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"D G Haller","raw_affiliation_strings":["Department of Medicine, University of Pennsylvania Cancer Center, The University of Pennsylvania School of Medicine, Philadelphia 19104, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Pennsylvania Cancer Center, The University of Pennsylvania School of Medicine, Philadelphia 19104, USA","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5069896983"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":0.1926,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.51465109,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"24","issue":"5 Suppl 18","first_page":"S18","last_page":"71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5175999999046326,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5175999999046326,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.30000001192092896,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10499","display_name":"Folate and B Vitamins Research","score":0.02199999988079071,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trimetrexate","display_name":"trimetrexate","score":1.0},{"id":"https://openalex.org/keywords/dihydrofolate-reductase-inhibitors","display_name":"dihydrofolate reductase inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.824999988079071},{"id":"https://openalex.org/keywords/methotrexate-resistance","display_name":"methotrexate resistance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/single-agent-chemotherapy","display_name":"single-agent chemotherapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8550000190734863},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8799999952316284},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/pediatric-renal-cell-carcinoma","display_name":"pediatric renal cell carcinoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.738949716091156},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5976429581642151},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5783253908157349},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.5298445224761963},{"id":"https://openalex.org/C2781382166","wikidata":"https://www.wikidata.org/wiki/Q50573407","display_name":"Antifolate","level":4,"score":0.5264050364494324},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.4755908250808716},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4532802700996399},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.38128662109375},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3754003047943115},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3401109576225281}],"mesh":[{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005493","descriptor_name":"Folic Acid Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016597","descriptor_name":"Trimetrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9420024","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9420024","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:2411288993","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9420024","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2271920406","https://openalex.org/W1988328608","https://openalex.org/W2412178722","https://openalex.org/W2009794857","https://openalex.org/W2041817630","https://openalex.org/W1958400262","https://openalex.org/W2398796448","https://openalex.org/W1997065239","https://openalex.org/W2049345149","https://openalex.org/W92728855"],"abstract_inverted_index":{"Trimetrexate":[0],"(TMTX),":[1],"a":[2,36,111,139],"potent":[3],"inhibitor":[4],"of":[5,27,38,46,55,58,67,102,114,128,142,148,169],"the":[6,43,56,103,132,146,167],"enzyme":[7],"dihydrofolate":[8],"reductase,":[9],"is":[10],"biochemically":[11],"and":[12,22,32,60,63,86,88,107,165],"metabolically":[13],"similar":[14],"to":[15,95,150],"methotrexate":[16],"(MTX).":[17],"Fundamental":[18],"differences":[19],"between":[20],"TMTX":[21,28,48,97,135,149,159],"MTX,":[23],"however,":[24],"mandate":[25],"investigation":[26],"in":[29,52,64,76],"both":[30,161],"MTX-sensitive":[31],"MTX-resistant":[33],"tumors.":[34],"In":[35,110],"number":[37],"phase":[39],"II":[40],"clinical":[41,121],"trials,":[42],"antitumor":[44],"activity":[45,72,122,127,164],"single-agent":[47,96,126,163],"has":[49,73],"been":[50,74],"variable,":[51],"part":[53,65],"because":[54,66],"heterogeneity":[57],"doses":[59],"schedules":[61],"used":[62],"diverse":[68],"patient":[69],"populations.":[70],"Single-agent":[71],"documented":[75],"some":[77],"commonly":[78],"occurring":[79],"tumors,":[80],"including":[81],"breast,":[82],"non-small":[83],"cell":[84,100,118],"lung,":[85],"head":[87],"neck":[89],"cancers.":[90],"Other":[91],"tumors":[92],"with":[93,116,131],"sensitivity":[94],"include":[98],"transitional":[99],"carcinomas":[101],"urothelium,":[104],"prostate":[105],"cancer,":[106],"gastric":[108],"carcinoma.":[109],"small":[112],"series":[113],"children":[115],"renal":[117],"carcinoma,":[119],"significant":[120],"was":[123],"suggested.":[124],"The":[125,156],"TMTX,":[129],"coupled":[130],"finding":[133],"that":[134,145,158],"may":[136,160],"act":[137],"as":[138],"biochemical":[140],"modulator":[141],"5-fluorouracil/leucovorin,":[143],"suggests":[144],"addition":[147],"5-fluorouracil/leucovorin":[151],"should":[152],"be":[153],"investigated":[154],"further.":[155],"possibility":[157],"exhibit":[162],"modulate":[166],"effectiveness":[168],"other":[170],"agents":[171],"makes":[172],"combination":[173],"therapy":[174],"attractive.":[175]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}